I., & Clemmons, D
In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
patients with obesity (35 U/L
The mean differences between left and right thalamic GSH were small and non-significant in all groups (HC: p = 0.570
Efficacy Semaglutide is effective for type 2 diabetes management and weight reduction
Choose brand-name (Wegovy or Ozempic) if: Your insurance covers it with a manageable copay You qualify for the FDA-approved indication (BMI threshold, T2D diagnosis) You prefer the standardization of FDA-registered manufacturing You want supporting clinical evidence directly applicable to what you are taking Consider compounded semaglutide if: You are paying cash or your insurance does not cover Wegovy You do not meet the FDA-approved BMI thresholds but want to start GLP-1 therapy under medical supervision You need a customized formulation (B12 combination, dose customization, allergen-free) Your physician has worked with reputable compounding pharmacies and can verify quality How to Access Each Brand: Doctor visit (primary care, endocrinologist, or weight-management specialist) prescription pharmacy fill insurance prior authorization or cash pay